日付

担当者

まとめ

Atezolizumab Treatment Beyond Progression in Advanced NSCLC: Results From the Randomized, Phase III OAK Study.

児玉

児玉

Neoadjuvant PD-1 Blockade in Resectable Lung Cancer.

金澤

石井

Angiotensin converting enzyme inhibitors and risk of lung cancer: population based cohort study 

大越

Three new disease-progression modes in NSCLC patients after EGFR-TKI treatment by next-generation sequencing analysis.

児玉

First-Line Atezolizumab plus Chemotherapy in Extensive-Stage Small-Cell Lung Cancer.

井部

Novel therapies for malignant pleural mesothelioma

Impact of Baseline Steroids on Efficacy of Programmed Cell Death-1 and

Programmed Death-Ligand 1 Blockade in Patients With Non-Small-Cell Lung Cancer

Influenza vaccination of cancer patients during PD-1 blockade induces serological protection but may raise the risk for immune-related adverse events

J. Immunotherapy of Cancer 2018

Safety of Programmed Death-1 Pathway Inhibitors Among Patients With Non-Small-Cell Lung Cancer and Preexisting Autoimmune Disorders

 JCO 2018

Cancer immunotherapy efficacy and patients’ sex: a systematic review and meta-analysis

Lancet 2018

Atezolizumab for First-Line Treatment of Metastatic Nonsquamous NSCLC

NEJM 2018

Comparison of an Oral Factor Xa Inhibitor With Low Molecular Weight Heparin in Patients

With Cancer With Venous Thromboembolism: Results of a Randomized Trial (SELECT-D)

JCO 2018

Outpatient Talc Administration by Indwelling Pleural Catheter for Malignant Effusion

NEJM 2018

Nivolumab plus Ipilimumab in Lung Cancer with a High Tumor Mutational Burden

NEJM 2018

Predictive performance of the quick Sequential Organ Failure Assessment score as a screening

tool for sepsis, mortality, and intensive care unit admission in patients with febrile neutropenia

Suppoet Care Cancer

2018

Pembrolizumab plus Chemotherapy in Metastatic Non-Small-Cell Lung Cancer

NEJM 2018

Outcomes in patients with non-small-cell lung cancer and acquired Thr790Met mutation treated with osimertinib: a genomic study

Lancet 2018

日付

担当者

まとめ

Reduced need for surgery in severe nasal polyposis with mepolizumab: Randomized trial.

濵元

Serious Asthma Events with Fluticasone plus Salmeterol versus Fluticasone Alone.

中村

Comparative effectiveness of LABA-ICS versus LAMA as initial treatment in COPD targeted by blood eosinophils: a population-based cohort study.

30343028

井上

（研）

日付

担当者

まとめ

Partial Oral versus Intravenous Antibiotic Treatment of Endocarditis

Association of 30-Day Mortality With Oral Step-Down vs Continued Intravenous Therapy in Patients Hospitalized With Enterobacteriaceae Bacteremia.

増谷

呉

Proactive Use of High-Flow Nasal Cannula With Critically Ill Subjects.

Baloxavir Marboxil for Uncomplicated Influenza in Adults and Adolescents.

 Prednisone for the Prevention of Paradoxical Tuberculosis-Associated IRIS.

A Randomized Trial of Itraconazole vs Prednisolone in Acute-Stage Allergic Bronchopulmonary

Aspergillosis Complicating Asthma

Procalcitonin-Guided Use of Antibiotics for Lower Respiratory Tract Infection

Management of severe sepsis in patients admitted to Asian intensive care units:

prospective cohort study

Predictive performance of the quick Sequential Organ Failure Assessment score as a screening tool for sepsis, mortality, and intensive care unit admission in patients with febrile neutropenia

日付

担当者

まとめ